Assyro AI

FDA Orange Book · active-ingredient family

Betaxolol hydrochloride

Betaxolol hydrochloride is approved as 3 brand and 6 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:BETOPTIC S · NDA 019845

3

Brand (NDA)

6

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · solution/drops, suspension/drops, tablet

ProductApplicantApplicationTEApproved
BETOPTIC SRLDNOVARTISNDA 019845Dec 29, 1989
BETOPTICRLDSANDOZNDA 019270ATAug 30, 1985
KERLONE×2SANOFI AVENTIS USNDA 019507Oct 27, 1989

Generic (ANDA) products (6)

ProductApplicantApplicationTEApproved
BETAXOLOL HYDROCHLORIDECHARTWELL RXANDA 078694ATNov 16, 2009
BETAXOLOL HYDROCHLORIDE×2KVK TECHANDA 078962ABJun 27, 2008
BETAXOLOL HYDROCHLORIDEEUROFARMAANDA 075630ATApr 12, 2001
BETAXOLOL HYDROCHLORIDEAPOTEX INCANDA 075446Sep 28, 2000
BETAXOLOL HYDROCHLORIDEPHARMOBEDIENTANDA 075386Jun 30, 2000
BETAXOLOL HYDROCHLORIDE×2EPIC PHARMAANDA 075541ABOct 22, 1999

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Betaxolol hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.